Sunday, 26 June, 2022
TopicWHO

Topic: WHO

WHO recommends two new Covid drugs, in discussions to secure ‘equitable access’

Extent to which Baricitinib & Sotrovimab will save lives depends on how available, affordable they will be, says WHO. New guidelines advise against use of Remdesivir, Ivermectin.

Africa’s Omicron-fuelled fourth Covid wave flattens out after 6-week surge, WHO says

Although the fourth wave of pandemic on the African continent has been the 'shortest-lived' surge, WHO warned that 'the next wave might not be so forgiving'.

Not just disease severity, 2 vaccine doses can also reduce impact of long Covid: Israeli study

Researchers find people vaccinated with at least two doses are less likely to suffer from long-term effects of Covid. Beneficial effect is more pronounced in the elderly.

Scientist who discovered the Omicron variant explains why a ‘global fund’ is a necessity

Rapid tracking of emerging pathogens or variants of concern of known pathogens is key to stopping the next pandemic, epidemic or outbreak.

WHO deploys team in South Africa to tackle Omicron variant as cases surge

A team of experts has been sent to the Gauteng province in South Africa, which has accounted for almost 80% of the cases over the past week.

Obesity is more than just calorie-in, calorie-out. Low carb diets aren’t enough

Good nutrition is beyond weight loss or theories. Obesity needs whole, practical, and sustainable diet planning.

With aim to tackle vaccine inequity, African firm tries to replicate Moderna Covid shot

Afrigen Biologics and Vaccines is relying on the US company’s pledge that it will not enforce its patent during the pandemic.

‘Our house is on fire’ in more ways than one. Climate change, Covid-19 ruining adolescents

There is no end in sight for crises. Adolescents have not been well served, according to the British Medical Journal.

WHO-Covaxin-Modi govt is a triangle of confusion. No one knows what’s going on

The fact that it’s taken so long for Covaxin to get approval casts doubt on not only Bharat Biotech, but also the regulatory process in India.

WHO, UN experts at launch of book on Covaxin even as Bharat Biotech awaits emergency listing

'Going Viral: The Inside Story of Covaxin', written by ICMR DG Dr Balram Bhargava, was handed over to WHO and UN officials by the author during an event at UNAIDS office in Geneva.

On Camera

YourTurn

Illustration: Ramandeep Kaur | ThePrint

Does breaking up big states boost economy? Data doesn’t back up hype, says Indian study

The study by researchers at Indira Gandhi Institute of Development Research looked at economic impact of reorganising Uttar Pradesh, Madhya Pradesh, and Bihar in the year 2000.

Defence

The Indian Air Force logo | Commons

Almost 4,000 enrol for IAF’s Agnipath recruitment scheme on day 1 of online registrations

These registrations pertain to the Indian Air Force's Agniveer Vayu programme. The online portal for the first phase was opened at 10 am Friday, and will close on 5 July.

With Agnipath, Modi govt’s shock & awe doctrine may have misfired a vital reform, yet again

Modi govt's biggest flaw has been its disinclination to accept limitations of electoral majorities. This ruined land acquisition and farm reform, stalled labour codes.
×